Idera: Novartis deal ends, Merck pact extended
Idera Pharmaceuticals Inc. on Wednesday announced the end of a research partnership with Novartis AG, but said Merck & Co. is extending its work with Idera for another year.
AP via Yahoo! News,
Wed Nov 25 09:14:21 PST 2009
• Found on Yahoo! News
KARO BIO ANNOUNCES THAT MERCK & CO., INC. PLANS TO PROCEED WITH PHASE II CLINICAL ...
Regulatory News: The Swedish biotech company Karo Bio (Reuters: KARO.ST) today announced that Merck Co., Inc., through an affiliate, ...
Finanzen.net,
Wed Nov 25 23:11:03 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Merck to commence MK-6913 phase IIa efficacy trial for treatment of hot flashes/ho...
The Swedish biotech company Karo Bio today announced that Merck & Co., Inc., through an affiliate, plans to enter a clinical phase IIa trial with the collaboration's lead investigational dr...
News-Medical-Net,
Thu Nov 26 00:06:19 PST 2009
• Found on Yahoo! News
Merck gets favourable judgement from US court against Flemings involving Fosamax
Merck said that US District Court Judge John F Keenan granted summary judgement in Merck's favour in Flemings v Merck. Flemings is the second of three cases involving Fosamax (alendronate s...
PharmaBiz,
Wed Nov 25 19:58:44 PST 2009
• Found on Yahoo! News
Merck's Relief in Texas
Merck's list of court cases on Vioxx continues.
Zacks.com via Yahoo! Finance,
Wed Nov 25 04:58:34 PST 2009
• Found on Yahoo! News
Idera: Novartis deal ends, Merck pact extended
Idera Pharma says Novartis ending allergy collaboration, Merck extends cancer research deal
Newsday,
Wed Nov 25 14:39:38 PST 2009
• Found on Yahoo! News
Idera: Novartis deal ends, Merck pact extended
Idera Pharmaceuticals Inc. on Wednesday announced the end of a research partnership with Novartis AG, but said Merck & Co. is extending its work with Idera for another year. Novartis, a Swi...
San Francisco Chronicle,
Wed Nov 25 10:00:18 PST 2009
• Found on Yahoo! News
Merck, Idera Pharmaceuticals extend their vaccine research collaboration
Idera Pharmaceuticals, Inc. today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a fourth year. In December 2006, the compani...
News-Medical-Net,
Wed Nov 25 21:06:57 PST 2009
• Found on Yahoo! News
Fifteen from Tampa Bay area among those who spoke on Merck's behalf
Health line15 LOCALS among those who spoke on Merck's behalf
St. Petersburg Times,
Wed Nov 25 13:36:23 PST 2009
• Found on Yahoo! News
Idera: Novartis deal ends, Merck pact extended
Idera Pharmaceuticals Inc. on Wednesday announced the end of a research partnership with Novartis AG, but said Merck & Co. is extending its work with Idera for another year.
San Diego Union-Tribune,
Wed Nov 25 12:59:15 PST 2009
• Found on Yahoo! News
Midday Glance: Pharmaceuticals companies
NEW YORK (AP) -- Shares of some top pharmaceuticals companies are mixed at noon: Baxter rose $.35 or .6 percent, to $55.10. Bristol-Myers Squibb fell $.28 or 1.1 percent, to $25.37. Hospira...
AP via Yahoo! Finance,
Fri Nov 27 10:03:18 PST 2009
• Found on Yahoo! News
Merck Serono Launches New Website on Phenylketonuria
GENEVA, November 25 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the launch of a website dedicated to phenylketonuria (PKU), a rare inborn met...
ITNews,
Wed Nov 25 04:12:34 PST 2009
• Found on Yahoo! News
Merck says key Fosamax lawsuit dismissed
Merck & Co. on Tuesday said a U.S. district court dismissed claims against the company in a second key case alleging the osteoporosis drug Fosamax causes painful jaw bone destruction.
AP via Yahoo! News,
Tue Nov 24 04:40:53 PST 2009
• Found on Yahoo! News
Merck to buy back up to $3 billion in stock
Merck & Co. Inc. said Tuesday it will repurchase up to $3 billion in stock, in a move intended to gather up equity issued recently to help it acquire Schering-Plough.
Market Watch,
Tue Nov 24 14:30:40 PST 2009
• Found on Yahoo! News
Early Glance: Pharmaceuticals companies
NEW YORK (AP) -- Shares of some top pharmaceuticals companies are down at 10 a.m.: Baxter fell $.14 or .2 percent, to $54.62. Bristol-Myers Squibb fell $.44 or 1.7 percent, to $25.21. Hospi...
AP via Yahoo! Finance,
Fri Nov 27 07:47:32 PST 2009
• Found on Yahoo! News
Merck declares dividend and $3B stock buyback
Drugmaker Merck & Co. declared a quarterly dividend of 38 cents on Tuesday, and said it plans to buy back as much as $3 billion in stock.
AP via Yahoo! Finance,
Tue Nov 24 12:45:46 PST 2009
• Found on Yahoo! News
Merck Chimie advances to the next phase in commercializing Beads, reports CardioGe...
CardioGenics Holdings Inc., a developer of technology and products targeting the immunoassay segment of the IVD testing market, reports that Merck Chimie S.A.S. ("Merck Chimie") is progress...
News-Medical-Net,
Wed Nov 25 03:51:57 PST 2009
• Found on Yahoo! News
Merck to close warehouse, lay off 80
Upper Macungie operations will be moved to New Jersey. Eighty people will lose their jobs starting in January when Merck & Co. closes an Upper Macungie Township warehouse and relocates the ...
The Morning Call,
Wed Nov 25 00:56:59 PST 2009
• Found on Yahoo! News
Merck To Buy Back $3 Bln In Common Shares
Merck To Buy Back $3 Bln In Common Shares
Fox News,
Tue Nov 24 13:01:05 PST 2009
• Found on Yahoo! News